Skip to main content
VCEL logo

VCEL · Vericel Corp

Track VCEL — free
Market Cap
$2.07B
Shares
51.21M

VCEL metrics

77 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$40.19
Market cap
$2.07B

Price action

19 metrics
Price change (1W)
-1.9%
Price change (30D)
-10.2%
Price change (3M)
+10.7%
Price change (6M)
+19.2%
Price change (YTD)
+11.6%
Price change (1Y)
+19.4%
Trailing year
Price change (5Y)
-28.7%
52-week high
$48.31
52-week low
$29.34
Change from 52-week high
-16.8%
Change from 52-week low
+37.0%
Annualized volatility
44.5%
Beta
0.9
RSI (14D)
35.6
Price vs SMA 50
-10.1%
Price vs SMA 200
+5.3%
Avg volume (3M)
563,210
Relative volume
0.6
Average dollar volume
$24.46M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
51.21M

Valuation

12 metrics
P / E (TTM)
83.7
Trailing earnings · reciprocal yield 1.2%
PEG ratio
1.4
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
6.8×
reciprocal yield 14.8%
P / book
5.6
reciprocal yield 17.9%
FCF yield
3.0%
TTM · current market cap
Buyback yield
P / FCF
33.6
reciprocal yield 3.0%
P / operating cash flow
29.7
reciprocal yield 3.4%
Earnings yield
1.2%

Historical valuation

8 metrics
P / E historical average (3Y)
955.3×
reciprocal yield 0.1%
P / E historical average (5Y)
955.3×
reciprocal yield 0.1%
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
74.6%
Operating margin
6.0%
Trailing 12 months
Net margin
7.9%
Gross profit (TTM)
$228.38M
Operating profit (TTM)
$18.23M
Net income (TTM)
$24.22M
Trailing 12 months
Diluted EPS (TTM)
$0.48
FCF margin
20.1%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$0.08

Growth

11 metrics
Revenue growth YoY
+22.5%
Year over year
Net income growth YoY
+59.4%
Revenue (TTM)
$306.30M
Trailing 12 months
EPS growth YoY
+60.0%
Shares change YoY
+3.9%
Year over year · more shares
Revenue CAGR (3Y)
+18.9%
Revenue CAGR (5Y)
+17.3%
EPS CAGR (3Y)
EPS CAGR (5Y)
+39.8%
FCF CAGR (3Y)
+34.9%
FCF CAGR (5Y)
+10.6%

Quality

14 metrics
Return on equity
6.5%
Return on assets
4.8%
Debt / equity
Current ratio
5.0
EBITDA (TTM)
$31.15M
Free cash flow (TTM)
$61.66M
Quick ratio
4.7
Interest coverage
28.5
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$125.36M
Total assets
$502.87M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$69.67M
Capital expenditures (TTM)
$8.01M
R&D (TTM)
$29.17M
SG&A (TTM)
$180.98M
Stock compensation (TTM)
$37.50M
R&D / revenue
9.5%
Stock compensation / revenue
12.2%

Ownership (13F)

3 metrics
13F filers
318
13F filer change QoQ
+37
Institutional ownership
108.1%

Short interest

3 metrics
Short interest
9.2%
Latest settlement · 11.5 days to cover
Days to cover
11.5d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.49M
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 887359 CUSIP 92346J108 13F (30d) 233 filings 224 filers Visit website Investor relations